These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1517806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
    Neu HC.
    Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
    Jones RN.
    Diagn Microbiol Infect Dis; 1991 Oct; 14(1):37-43. PubMed ID: 2013209
    [Abstract] [Full Text] [Related]

  • 6. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
    Knothe H, Shah PM, Eckardt O.
    Infection; 1991 Oct; 19(5):370-6. PubMed ID: 1800379
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
    Lehtonen L, Huovinen P.
    Scand J Infect Dis; 1993 Oct; 25(3):373-8. PubMed ID: 8362234
    [Abstract] [Full Text] [Related]

  • 8. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A, Blandino G, Nicoletti G.
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [Abstract] [Full Text] [Related]

  • 9. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR, Huang WK, Shyr JM, Lau YJ, Liu YC, Luh KT.
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
    Yamada T, Yokota Y, Ikeda F, Mine Y, Kitada T.
    Chemotherapy; 1992 Sep; 38(1):28-35. PubMed ID: 1618001
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of cefixime: correlation index between MIC and disc diffusion test.
    Focà A, Liberto MC, Berlinghieri MC, Matera G, Puccio R, Carbone M, Fera MT.
    Drugs Exp Clin Res; 1990 Sep; 16(4):175-9. PubMed ID: 2076653
    [Abstract] [Full Text] [Related]

  • 17. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
    Johnson DM, Jones RN.
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
    Mulligan ME.
    Infect Control; 1987 Jun; 8(6):241-4. PubMed ID: 3498702
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
    Neu HC, Chick TW.
    Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N, Nakamura H, Kasai K, Ozaki T, Matsui Y, Tauchi N, Yamaguchi H, Taneda Y, Maki T.
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.